Home » Newsletters » BioWorld Science

BioWorld Science

Sep. 1, 2017

View Archived Issues

Fujifilm to begin clinical testing of FF-10832 for advanced solid tumors next year

FDA issues refusal to file letter for SteadyMed's Trevyent NDA

Akcea announces NDA submission for volanesorsen in familial chylomicronemia syndrome

Bayer submits BLA to FDA for BAY-94-9027

Sunovion files NDA for dasotraline to treat ADHD

Daiichi Sankyo terminates agreement with Charleston Laboratories

Topline results from Asian REDUCER trial of mirogabalin in diabetic peripheral neuropathic pain

Sumitomo Dainippon Pharma submits an application in Japan for an additional indication for Trerief

Bristol-Myers Squibb explores adaptor-associated kinase 1 as a target for neuropathic pain

Thermo Fisher forms European Immuno-Oncology Consortium

Serum APEX found a marker of myocarditis severity

European Commission approves pediatric formulation of Mimpara

Mochida compound shows effective targeting of FFAR1 for diabetes

Horizon Discovery completes acquisition of GE Healthcare Dharmacon

Aptevo and MorphoSys end partnership for MOR-209

FDA awards fast track designation to Iovance's LN-144 for advanced melanoma

Taisho Pharmaceutical presents 20-HETE synthase inhibitors

Heptares begins leukotriene receptor modulator collaboration with Juntendo University

ImMAGE Biotherapeutics terminates operations

Roche and Genentech patent new Janus kinase inhibitors

Sprint Bioscience AB divulges PIK3C3 inhibitors

RegeneRx completes license expansion agreement with GtreeBNT for RGN-137

Oragenics initiates phase II trial of AG-013 for oral mucositis

Janssen Vaccines & Prevention BV patent adenoviral vectors for treating malaria

Penn State Research Foundation divulges CCK2 receptor-targeting DNA aptamers

Novel compounds target MYC via G-quadruplex in the promoter region

Janssen Biotech terminates duvortuxizumab agreement with MacroGenics

Novel susceptibility loci identified for aortic aneurysm in Japanese individuals

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 13, 2026.
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...